BNS vs IBN
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The Bank of Nova Scotia (BNS) exhibits a weak financial health profile with a Piotroski F-Score of 2/9, signaling significant concerns in profitability, leverage, and operating efficiency. Despite this, the stock shows strong recent earnings growth (YoY EPS +58.2%) and a robust dividend yield of 4.28%, supported by a high but sustainable payout ratio. Valuation metrics suggest the stock is trading slightly above analyst targets ($74.87 vs. $70.40) and above the Graham Number of $68.74, though below the growth-based intrinsic value of $121.54. Technical indicators are bearish (10/100), and insider sentiment is neutral, reflecting limited conviction despite solid dividend strength.
The deterministic health profile is concerning, highlighted by a weak Piotroski F-Score of 2/9, indicating deteriorating operational trends. However, the valuation remains attractive with a PEG ratio of 0.52 and a current price ($27.54) sitting below the growth-based intrinsic value of $31.16. While revenue growth is explosive at 66.90%, the technical trend is currently bearish (0/100) and the 1-year price performance is negative. The stock presents a conflict between strong growth/valuation metrics and poor short-term financial health and price momentum.
Compare Another Pair
Related Comparisons
BNS vs IBN: Head-to-Head Comparison
This page compares The Bank of Nova Scotia (BNS) and ICICI Bank Limited (IBN) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.